Biopharmadive

Published October 14, 2026

Experimental Arrowhead RNAi drug hints at Alzheimer's benefit - BioPharma Dive

Read the full story at Biopharmadive

psychedelic brain Aug. 12, 2026. Psychedelics developer Definium scores more positive data for LSD pill · A headshot of Kabir Nath, CEO of Compass.